Industry: Service & Software
Published Date: 2026-07-24
Pages: 111 Pages
Report ld: 6980881
Request Sample
Customized Report
Biomedical Knowledge Graph Platform Market Size(US$)

CAGR 2026-2032
29.5%
Market Size,2032
USD 1,406
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Biomedical Knowledge Graph Platform was estimated to be worth US$ 230 million in 2025 and is projected to reach US$ 1406 million, growing at a CAGR of 29.5% from 2026 to 2032.
A biomedical knowledge graph platform is a software platform for pharmaceutical R&D, clinical research, and life science data management. It connects literature, omics, diseases, targets, drugs, clinical trials, and real-world data into a searchable, explainable, and updatable knowledge network through ontology modeling, entity recognition, relation extraction, graph databases, semantic search, and reasoning algorithms. It is mainly used for evidence retrieval, target discovery, drug repurposing, mechanism analysis, clinical decision support, and R&D knowledge management, and is typically delivered through SaaS subscription, private deployment, or custom projects, with a blended gross margin of about 70%.
Demand is mainly driven by pharmaceutical companies, biotech firms, research institutes, hospitals, and CROs that need to integrate high-quality biomedical data. As scientific literature, omics datasets, patents, clinical trials, and real-world evidence continue to expand, keyword search and isolated databases are no longer sufficient for cross-entity and evidence-chain analysis. Biomedical knowledge graph platforms are becoming core infrastructure for target screening, drug repurposing, indication expansion, and evidence tracking.
Competition is shifting from standalone graph databases and visualization tools toward integrated capabilities that combine domain ontologies, data cleaning, evidence provenance, semantic reasoning, graph machine learning, and LLM-enhanced retrieval. Leading vendors build barriers around high-quality medical corpora, proprietary ontologies, automated extraction models, expert validation workflows, and API integration. Buyers usually focus on data credibility, update frequency, explainability, access control, compliance, and integration cost with internal R&D systems.
North America and Europe remain the main demand centers, supported by large pharmaceutical companies, AI drug discovery companies, and research hospitals, while Asia-Pacific is growing with higher innovative drug investment, domestic database initiatives, and hospital research digitalization. Key risks include data copyright, privacy compliance, delayed updates of medical facts, and trust issues in generative AI outputs. Opportunities are concentrated in private deployment, enterprise knowledge base integration, multi-omics and clinical data linkage, and graph services for research agents.
MARKET SEGMENTATION
REPORT SCOPE
This report provides a comprehensive view of the global market for Biomedical Knowledge Graph Platform, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biomedical Knowledge Graph Platform market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biomedical Knowledge Graph Platform.
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Biomedical Knowledge Graph Platform companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biomedical Knowledge Graph Platform revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biomedical Knowledge Graph Platform revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Biomedical Knowledge Graph Platform Product Introduction
1.2 Global Biomedical Knowledge Graph Platform Market Size Forecast (2021–2032)
1.3 Biomedical Knowledge Graph Platform Market Trends & Drivers
1.3.1 Biomedical Knowledge Graph Platform Industry Trends
1.3.2 Biomedical Knowledge Graph Platform Market Drivers & Opportunities
1.3.3 Biomedical Knowledge Graph Platform Market Challenges
1.3.4 Biomedical Knowledge Graph Platform Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biomedical Knowledge Graph Platform Players Revenue Ranking (2025)
2.2 Global Biomedical Knowledge Graph Platform Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Biomedical Knowledge Graph Platform Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Biomedical Knowledge Graph Platform
2.6 Biomedical Knowledge Graph Platform Market Competitive Analysis
2.6.1 Biomedical Knowledge Graph Platform Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Biomedical Knowledge Graph Platform Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biomedical Knowledge Graph Platform revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Biomedical Knowledge Graph Platform Market Classification
3.1 Introduction by Type
3.1.1 Cloud SaaS Platform
3.1.2 Private Deployment Platform
3.1.3 Hybrid Deployment Platform
3.1.4 Custom Project Platform
3.1.5 Global Biomedical Knowledge Graph Platform Sales Value by Type
3.1.5.1 Global Biomedical Knowledge Graph Platform Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Biomedical Knowledge Graph Platform Sales Value, by Type (2021–2032)
3.1.5.3 Global Biomedical Knowledge Graph Platform Sales Value, by Type (%), 2021–2032
3.2 Introduction by Data Coverage
3.2.1 Literature Knowledge Graph
3.2.2 Multi-Omics Knowledge Graph
3.2.3 Clinical and RWE Knowledge Graph
3.2.4 Drug Discovery Knowledge Graph
3.2.5 Integrated Biomedical Knowledge Graph
3.2.6 Global Biomedical Knowledge Graph Platform Sales Value by Data Coverage
3.2.6.1 Global Biomedical Knowledge Graph Platform Sales Value by Data Coverage (2021 vs 2025 vs 2032)
3.2.6.2 Global Biomedical Knowledge Graph Platform Sales Value, by Data Coverage (2021–2032)
3.2.6.3 Global Biomedical Knowledge Graph Platform Sales Value, by Data Coverage (%), 2021–2032
3.3 Introduction by Graph Architecture
3.3.1 RDF Triple Store Platform
3.3.2 Labeled Property Graph Platform
3.3.3 Hybrid Graph and Vector Platform
3.3.4 Graph Database and Analytics Platform
3.3.5 Ontology-Centered Semantic Platform
3.3.6 Global Biomedical Knowledge Graph Platform Sales Value by Graph Architecture
3.3.6.1 Global Biomedical Knowledge Graph Platform Sales Value by Graph Architecture (2021 vs 2025 vs 2032)
3.3.6.2 Global Biomedical Knowledge Graph Platform Sales Value, by Graph Architecture (2021–2032)
3.3.6.3 Global Biomedical Knowledge Graph Platform Sales Value, by Graph Architecture (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharma and Biotech
4.1.2 CRO and Clinical Services
4.1.3 Hospitals and Healthcare Institutions
4.1.4 Academic Research
4.1.5 Public Health and Regulation
4.1.6 Others
4.2 Global Biomedical Knowledge Graph Platform Sales Value by Application
4.2.1 Global Biomedical Knowledge Graph Platform Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Biomedical Knowledge Graph Platform Sales Value by Application (2021–2032)
4.2.3 Global Biomedical Knowledge Graph Platform Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Biomedical Knowledge Graph Platform Sales Value by Region
5.1.1 Global Biomedical Knowledge Graph Platform Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Biomedical Knowledge Graph Platform Sales Value by Region (2021–2026)
5.1.3 Global Biomedical Knowledge Graph Platform Sales Value by Region (2027–2032)
5.1.4 Global Biomedical Knowledge Graph Platform Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Biomedical Knowledge Graph Platform Sales Value, 2021–2032
5.2.2 North America Biomedical Knowledge Graph Platform Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Biomedical Knowledge Graph Platform Sales Value, 2021–2032
5.3.2 Europe Biomedical Knowledge Graph Platform Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Biomedical Knowledge Graph Platform Sales Value, 2021–2032
5.4.2 Asia Pacific Biomedical Knowledge Graph Platform Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Biomedical Knowledge Graph Platform Sales Value, 2021–2032
5.5.2 South America Biomedical Knowledge Graph Platform Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biomedical Knowledge Graph Platform Sales Value, 2021–2032
5.6.2 Middle East & Africa Biomedical Knowledge Graph Platform Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biomedical Knowledge Graph Platform Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.3 United States
6.3.1 United States Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.3.2 United States Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.4.2 Europe Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.5.2 China Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.5.3 China Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.6.2 Japan Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.7.2 South Korea Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.8.2 Southeast Asia Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Biomedical Knowledge Graph Platform Sales Value, 2021–2032
6.9.2 India Biomedical Knowledge Graph Platform Sales Value by Type (%), 2025 vs 2032
6.9.3 India Biomedical Knowledge Graph Platform Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Causaly
7.1.1 Causaly Profile
7.1.2 Causaly Main Business
7.1.3 Causaly Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.1.4 Causaly Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.1.5 Causaly Recent Developments
7.2 BenchSci
7.2.1 BenchSci Profile
7.2.2 BenchSci Main Business
7.2.3 BenchSci Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.2.4 BenchSci Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.2.5 BenchSci Recent Developments
7.3 Insilico Medicine
7.3.1 Insilico Medicine Profile
7.3.2 Insilico Medicine Main Business
7.3.3 Insilico Medicine Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.3.4 Insilico Medicine Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.3.5 Insilico Medicine Recent Developments
7.4 BenevolentAI
7.4.1 BenevolentAI Profile
7.4.2 BenevolentAI Main Business
7.4.3 BenevolentAI Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.4.4 BenevolentAI Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.4.5 BenevolentAI Recent Developments
7.5 Healx
7.5.1 Healx Profile
7.5.2 Healx Main Business
7.5.3 Healx Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.5.4 Healx Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.5.5 Healx Recent Developments
7.6 SciBite
7.6.1 SciBite Profile
7.6.2 SciBite Main Business
7.6.3 SciBite Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.6.4 SciBite Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.6.5 SciBite Recent Developments
7.7 Ontotext
7.7.1 Ontotext Profile
7.7.2 Ontotext Main Business
7.7.3 Ontotext Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.7.4 Ontotext Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.7.5 Ontotext Recent Developments
7.8 Stardog
7.8.1 Stardog Profile
7.8.2 Stardog Main Business
7.8.3 Stardog Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.8.4 Stardog Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.8.5 Stardog Recent Developments
7.9 Neo4j
7.9.1 Neo4j Profile
7.9.2 Neo4j Main Business
7.9.3 Neo4j Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.9.4 Neo4j Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.9.5 Neo4j Recent Developments
7.10 Eagle Genomics
7.10.1 Eagle Genomics Profile
7.10.2 Eagle Genomics Main Business
7.10.3 Eagle Genomics Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.10.4 Eagle Genomics Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.10.5 Eagle Genomics Recent Developments
7.11 Lifebit
7.11.1 Lifebit Profile
7.11.2 Lifebit Main Business
7.11.3 Lifebit Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.11.4 Lifebit Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.11.5 Lifebit Recent Developments
7.12 Elsevier
7.12.1 Elsevier Profile
7.12.2 Elsevier Main Business
7.12.3 Elsevier Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.12.4 Elsevier Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.12.5 Elsevier Recent Developments
7.13 Heal Intellect
7.13.1 Heal Intellect Profile
7.13.2 Heal Intellect Main Business
7.13.3 Heal Intellect Biomedical Knowledge Graph Platform Products, Services, and Solutions
7.13.4 Heal Intellect Biomedical Knowledge Graph Platform Revenue (US$ Million), 2021–2026
7.13.5 Heal Intellect Recent Developments
8 Industry Chain Analysis
8.1 Biomedical Knowledge Graph Platform Value Chain
8.2 Biomedical Knowledge Graph Platform Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Biomedical Knowledge Graph Platform Sales Model
8.5.2 Sales Channels
8.5.3 Biomedical Knowledge Graph Platform Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Biomedical Knowledge Graph Platform market size was US$ 230 million in 2025 and is forecast to reach a readjusted size of US$ 1406 million by 2032 with a CAGR of 29.5% during the forecast period 2026-2032.
Published Date: 2026-07-24
Pages: 119
USD 4250.00
(Single User License)
The global Biomedical Knowledge Graph Platform market is projected to grow from US$ 230 million in 2025 to US$ 1406 million by 2032, at a CAGR of 29.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-24
Pages: 144
USD 4900.00
(Single User License)
The global Biomedical Knowledge Graph Platform market was valued at US$ 230 million in 2025 and is anticipated to reach US$ 1406 million by 2032, at a CAGR of 29.5% from 2026 to 2032.
Published Date: 2026-07-24
Pages: 114
USD 2900.00
(Single User License)
The global Biomedical Knowledge Graph Platform market size was US$ 230 million in 2025 and is forecast to reach a readjusted size of US$ 1406 million by 2032 with a CAGR of 29.5% during the forecast period 2026-2032.
Published: 2026-07-24
Pages: 119
The global Biomedical Knowledge Graph Platform market is projected to grow from US$ 230 million in 2025 to US$ 1406 million by 2032, at a CAGR of 29.5% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-24
Pages: 144
The global Biomedical Knowledge Graph Platform market was valued at US$ 230 million in 2025 and is anticipated to reach US$ 1406 million by 2032, at a CAGR of 29.5% from 2026 to 2032.
Published: 2026-07-24
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now